PTX3 and cancer: Meanwhile, cancer cells succumbing to inhibition were observed using a methylation inhibitor, 5-Aza-2'-deoxycytidine, which could sustain PTX3 expression, implying that PTX3 may serve as a potential therapeutic target 32.